Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03706313 · ClinicalTrials.gov registry record · Phase 4

Genicular Nerve Block for Total Knee Arthroplasty

A Phase 4 study of Postoperative Pain, sponsored by Duke University.

Completed
Registry status
Phase 4
Development phase
40
Enrollment target
1
Study location

NCT03706313: Completed Phase 4 study of Postoperative Pain, sponsored by Duke University.

NCT03706313 is a Phase 4 study of Postoperative Pain that has completed, run by Duke University. The registered enrollment target is 40 participants, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03706313, a Phase 4 study of Postoperative Pain, has completed, sponsored by Duke University.

COMPLETED
Registry status
Phase 4
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study seeks to examine the analgesic efficacy of genicular nerve blocks for pain after total knee replacement.

Primary Outcome

Opioid consumption documented in medical recorded will be converted to oral morphine equivalents.

Conditions Studied

Interventions

  • DRUG Saline
  • DRUG 15mL 0.25% bupivacaine
  • PROCEDURE Genicular nerve block

Study Locations (1)

North Carolina

  • Duke University Hospital - Durham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2019-01-15
Est. Completion 2019-10-22
Phase Phase 4
Duke University

1,725 total trials

What the finished NCT03706313 record still lists

NCT03706313 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 3 interventions - of which Saline is the first listed.

NCT03706313 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03706313 about?

NCT03706313 is a clinical study titled "Genicular Nerve Block for Total Knee Arthroplasty". This study seeks to examine the analgesic efficacy of genicular nerve blocks for pain after total knee replacement.

What is the current status of trial NCT03706313?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2019-01-15. Estimated completion is 2019-10-22.

What conditions does trial NCT03706313 study?

This clinical trial studies the following conditions: Postoperative Pain.

What interventions are being tested in trial NCT03706313?

The interventions under investigation include: Saline (DRUG), 15mL 0.25% bupivacaine (DRUG), Genicular nerve block (PROCEDURE).

Who is sponsoring clinical trial NCT03706313?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03706313 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03706313's enrollment target sits among peer trials

40 109th of 120 higher than 10 of 120 other Postoperative Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03706313, the US trial registry maintained by the National Library of Medicine. NCT03706313 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.